Annual report pursuant to Section 13 and 15(d)

Goodwill and Intangible Assets Notes

v3.20.4
Goodwill and Intangible Assets Notes
 12 Months Ended
Dec. 31, 2018
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets Goodwill and Intangible Assets
Goodwill

    Goodwill arises from the acquisition method of accounting for business combinations and represents the excess of the purchase price over the fair value of the net assets and other identifiable intangible assets acquired. The fair values of net tangible assets and intangible assets acquired are based upon preliminary valuations and the Company’s estimates and assumptions are subject to change within the measurement period (potentially up to one year from the acquisition date).

The following table presents the changes in the carrying amount of goodwill for the periods indicated:    
Years Ended December 31,
2020 2019
(in thousands)
Beginning balance $ 238,330  $ 238,330 
Acquisitions (Note 3) 64,498  — 
Ending balance $ 302,828  $ 238,330 

    The Company performs an annual goodwill impairment assessment on October 31st each year, using a quantitative assessment comparing the fair value of each reporting unit, which the Company has determined to be the entity itself, with its carrying amount, including goodwill. If the carrying amount of a reporting unit exceeds its fair value, an impairment loss is recorded.
As a result of the Company's impairment assessment, no goodwill impairment was recognized as of October 31, 2020. In addition to its annual review, the Company performs a test of impairment when indicators of impairment are present. As of December 31, 2020, there were no indications of impairment of the Company’s goodwill balances.
Acquired Intangibles
    Finite-lived Intangible Assets
    The following table sets forth the Company’s finite-lived intangible assets resulting from business acquisitions and other purchases, which continue to be amortized:
December 31, 2020 December 31, 2019
Weighted
Average
Useful Life
(in Years)		 Gross Carrying Amount Accumulated Amortization Net Carrying Amount Gross Carrying Value Accumulated Amortization Net Carrying Amount
(in thousands)
Licensed technology 5.9 $ 4,869  $ (2,006) $ 2,863  $ 2,156  $ (1,583) $ 573 
Developed technology 6.9 304,061  (146,252) 157,809  243,361  (108,522) 134,839 
Trademarks and trade names 6.2 14,800  (8,818) 5,982  13,800  (6,511) 7,289 
Customer relationships 4.6 128,800  (96,047) 32,753  121,100  (75,847) 45,253 
Non-compete covenants 3.0 1,100  (1,100) —  1,100  (1,083) 17 
Backlog 2.4 1,300  (641) 659  —  —  — 
6.2 $ 454,930  $ (254,864) $ 200,066  $ 381,517  $ (193,546) $ 187,971 

The following table sets forth amortization expense associated with finite-lived intangible assets, which is included in the consolidated statements of operations as follows:
Years Ended December 31,
2020 2019 2018
Cost of net revenue $ 37,784  $ 33,932  $ 35,821 
Research and development 5  48  150 
Selling, general and administrative 23,529  23,035  31,976 
$ 61,318  $ 57,015  $ 67,947 

Amortization of finite-lived intangible assets in cost of net revenue in the consolidated statements of operations results primarily from acquired developed technology.

The following table sets forth activity during the years ended December 31, 2020 and 2019 related to finite-lived intangible assets:
Years Ended December 31,
2020 2019
(in thousands)
Beginning balance $ 187,971  $ 240,500 
Acquisitions (Note 3) 70,700  — 
Other additions 2,799  86 
Transfers to developed technology from IPR&D —  4,400 
Amortization (61,318) (57,015)
Impairment losses (86) — 
Ending balance $ 200,066  $ 187,971 
The Company regularly reviews the carrying amounts of its long-lived assets subject to depreciation and amortization, as well as the related useful lives, to determine whether indicators of impairment may exist which warrant adjustments to carrying values or estimated useful lives. An impairment loss is recognized when the sum of the expected future undiscounted net cash flows is less than the carrying amount of the asset. Should impairment exist, the impairment loss is measured based on the excess of the carrying amount of the asset over the asset’s fair value. During the year ended December 31, 2019, no impairment losses related to finite-lived intangible assets were recognized. Impairment losses related to finite-lived intangible assets for the year ended December 31, 2020 was $0.1 million and related to purchased licensed technology and for the year ended December 31, 2018 was $2.2 million and related to acquired developed technology.

The following table presents future amortization of the Company’s finite-lived intangible assets at December 31, 2020:
Amortization
(in thousands)
2021 $ 66,772 
2022 48,908 
2023 36,802 
2024 20,804 
2025 10,706 
Thereafter 16,074 
Total $ 200,066 
    Indefinite-lived Intangible Assets
Indefinite-lived intangible assets consist entirely of acquired in-process research and development technology, or IPR&D. The following table sets forth the Company’s activities related to the indefinite-lived intangible assets:
Years Ended December 31,
2020 2019
(in thousands)
Beginning balance $ —  $ 4,400 
Acquisitions (Note 3) 7,200  — 
Transfers to developed technology from IPR&D —  (4,400)
Ending balance $ 7,200  $ — 
The Company performs its annual assessment of indefinite-lived intangible assets on October 31 each year or more frequently if events or changes in circumstances indicate that the asset might be impaired utilizing a qualitative test as a precursor to the quantitative test comparing the fair value of the assets with their carrying amount. Based on the qualitative test, if it is more likely than not that indicators of impairment exists, the Company proceeds to perform a quantitative analysis. Based on the Company’s assessment as of October 31, 2020, no indicators of impairment were identified. In the years ended December 31, 2020, 2019 and 2018, no IPR&D impairment losses were recorded.